β¨ Medicines Distribution Consent
NEW ZEALAND GAZETTE, No. 26
10 MARCH 2011
Product:
Listerine Tartar Control Antiseptic Mouthwash
Active Ingredients:
Benzoic acid 0.105%w/v
Cineole 0.092%w/v
Ethanol 22.5%v/v
Thymol 0.064%w/v
Zinc chloride 0.09%w/v
Dosage Form:
Mouthwash
New Zealand Sponsor:
Johnson & Johnson (New Zealand) Limited
Manufacturers:
Ensign Laboratories Pty Limited, Mulgrave, Australia
IDS Manufacturing Limited, Pathumthani, Thailand
McNeil Manufacturing Pty Limited, Taren Point, Australia
Product:
Listerine Teeth Defence
Active Ingredients:
Benzoic acid 1.5mg/mL
Cineole 0.92mg/mL
Ethanol 0.22mL/mL
Sodium fluoride 0.22mg/mL
Thymol 0.64mg/mL
Dosage Form:
Mouthwash
New Zealand Sponsor:
Johnson & Johnson (New Zealand) Limited
Manufacturers:
Ensign Laboratories Pty Limited, Mulgrave, Australia
IDS Manufacturing Limited, Pathumthani, Thailand
Product:
Ovidrel
Active Ingredient:
Choriogonadotropin alfa 250Β΅g
Dosage Form:
Solution for injection
Pre-filled syringe
Active Ingredient:
Choriogonadotropin alfa 250Β΅g
Dosage Form:
Solution for injection
Pen Injector
New Zealand Sponsor:
Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturers:
Merck Serono SpA, Bari, Italy
Merck Serono SA, Aubonne, Switzerland
Product:
Sprycel
Active Ingredient:
Dasatinib 20mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Bristol-Myers Squibb (NZ) Limited
Manufacturer:
Bristol-Myers Squibb Company, Indiana, United States of America
Product:
Sprycel
Active Ingredient:
Dasatinib 50mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Bristol-Myers Squibb (NZ) Limited
Manufacturer:
Bristol-Myers Squibb Company, Indiana, United States of America
Product:
Sprycel
Active Ingredient:
Dasatinib 70mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Bristol-Myers Squibb (NZ) Limited
Manufacturer:
Bristol-Myers Squibb Company, Indiana, United States of America
Product:
Sprycel
Active Ingredient:
Dasatinib 100mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Bristol-Myers Squibb (NZ) Limited
Manufacturer:
Bristol-Myers Squibb Company, Indiana, United States of America
Dated this 3rd day of March 2011.
MARK JACOBS, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go1507
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Next Page →
β¨ LLM interpretation of page content
π₯
Consent to the Distribution of New Medicines under the Medicines Act 1981
(continued from previous page)
π₯ Health & Social Welfare3 March 2011
Medicines, Distribution, Consent, Listerine, Ovidrel, Sprycel
- MARK JACOBS, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation, Ministry of Health
NZ Gazette 2011, No 26